From: A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes
Number
16
Mean Age
51.8 (35–75 years)
Histology
Squamous
16 (100%)
FIGO Stage*
IIB
8 (50%)
IIIB
Performance Status**
0
10 (62%)
1
6 (38%)